- SCA reported first-quarter Ebitda of SEK1.65 billion, which was below the estimated SEK1.67 billion.
- Net sales for the quarter came in at SEK5.16 billion, slightly above the forecast of SEK5.15 billion.
- Net income reported by SCA was SEK800 million.
- Operating profit for the company stood at SEK1.12 billion for the first quarter.
- Analyst recommendations for SCA include 9 buy ratings, 7 hold ratings, and 2 sell ratings.
A look at Svenska Cellulosa Ab Sca Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 5 | |
| Dividend | 3 | |
| Growth | 3 | |
| Resilience | 4 | |
| Momentum | 3 | |
| OVERALL SMART SCORE | 3.6 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Looking ahead, Svenska Cellulosa AB (SCA) appears to have a promising long-term outlook according to Smartkarma Smart Scores. With a top score in the Value category, the company is deemed to be well-positioned in terms of its financial health and valuation. SCA also demonstrates strength in Resilience, indicating its ability to weather market uncertainties and disruptions. While the company’s Growth and Momentum scores are moderate, SCA still maintains a solid overall outlook based on these factors.
Svenska Cellulosa AB (SCA) is a global hygiene and forest company known for developing and producing personal care products, tissue, and forest items. With a strong focus on sustainability, SCA markets its branded products worldwide, catering to a diverse consumer base. The company’s competitive standing is further reinforced by its respectable scores in Dividend and Growth, alongside robust performances in Value and Resilience, as indicated by the Smartkarma Smart Scores.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
